Loading company…
Meridian Bioscience develops and manufactures molecular and immunological reagents used in diagnostic testing.
Founded in 1977 and headquartered in Cincinnati, US, Meridian Bioscience, Inc. makes molecular and immunological reagents for diagnostic applications, including Specimen-specific™ Inhibitor Tolerant Master Mixes and qPCR reagents. Its most recent round was a Public to Private Secondary Buyout raising USD 1,530.00 mn, with SD Biosensor, Inc. and SJL Partners among the latest investors. The company is at Late stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in